4Andre P, NanizziAlaimo L, Prasad SK, et al. Platelet derived CD62P: The switch hitting platyer of cardio vascular disease. Circulation, 2004,106 (15):896-898.
5Platelet receptor inhibition in ischemic syndrome manage ment(PRJSM) study investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. NEngJ Med,2003,338(23):1498-1505.
2Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Natrue, 1998, 391: 159-594.
3Graf D, Mullar S, Korthauer U, et al. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol, 1995, 25: 1749-1754.
4Andre P, Nannizzi-Alaimo L, Prasad SK, et al. Plateletderived CD40L: the switch-hitting platyer of cardiovascular disease. Circulation, 2002; 106:896-898.
5Wagner AH, Gebauer M. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastation in human endothelial cells. Arterioscler Thromb.
6Cyrus T, Sung, S, Zhao L, et al. Effect of low-dose aspirin on vascular inflammation, plaque stability, and antherogenesis in low-density lipoprotein receptor-deficinent mice. Circulation, 2002, 106 (10) : 1282-1287.
7Platelet receptor inhibition in ischemic syndrome management(PRISM) study investigators. A comparison of aspirin plus tirofiban with aspirin plus heprin for unstable angina. N Engl J Med, 1998, 338:1498-1505.
8The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein Ⅱ b/Ⅲ a receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.N Engl J Med,1998,338:1488-1497.
9The RESTORE Investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997,96:1445- 1453.
1Fuster V, Badimon L, Badimon J J, et al.The pat hogenesis ofcoronary artery disease and the acute coronary syndromes [J]. N Engl J Med, 1992, 326 : 242-250.
2The PRISM2PLUS. Study Investigators. Inhibition of the plate-let glyeoprotein b/a receptor with tirofiban in unstable angina and non-Q-wave myocardial infaretion[J].N Engl J Med, 1998, 338 : 1488-1497.
3The RESTORE Investigators. Effect s of platalet glycoprotein II a/Ⅲ b blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarctionundergoing coronary angioplasty [J].Circulation, 1997, 96:1445-1453.
4Platelet receptor inhibition in ischemic syndrome management (PRISM) study investigators.A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina[J] .N Engl J Med, 1998, 338 : 1498-1505.
